Baird Medical Investment (NASDAQ:BDMD) Stock Price Up 1.3% – What’s Next?

Shares of Baird Medical Investment Holdings Limited (NASDAQ:BDMD) rose 1.3% on Wednesday. The stock traded as high as $0.8121 and last traded at $0.79. Approximately 64,460 shares traded hands during trading, a decline of 4% from the average daily volume of 67,241 shares. The stock had previously closed at $0.7801.

Analyst Ratings Changes

Separately, Weiss Ratings cut shares of Baird Medical Investment from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

Baird Medical Investment Stock Performance

The stock has a 50-day moving average of $1.03 and a 200-day moving average of $1.32.

Institutional Trading of Baird Medical Investment

A hedge fund recently bought a new stake in Baird Medical Investment stock. Citadel Advisors LLC bought a new position in Baird Medical Investment Holdings Limited (NASDAQ:BDMD) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 54,895 shares of the company’s stock, valued at approximately $63,000. Citadel Advisors LLC owned about 0.13% of Baird Medical Investment at the end of the most recent quarter. Hedge funds and other institutional investors own 19.78% of the company’s stock.

Baird Medical Investment Company Profile

Baird Medical Investment Holdings Limited is a medical device company focused on minimally invasive treatment technologies. Through its operating subsidiaries, the company develops, manufactures and sells microwave ablation systems and related medical products used in the treatment of thyroid nodules and other conditions.

Its product portfolio includes microwave ablation equipment, disposable ablation needles and associated accessories designed for use with ultrasound guidance. Baird Medical also provides related technical support, physician training and medical services intended to facilitate the adoption of microwave ablation procedures in clinical settings.

The company primarily serves hospitals and medical institutions in China and has worked to expand the use of its technologies across the country.